Zdrowie i gospodarka · 06/10/2015
FDA Releases Guidance on Draft Labeling for Abbreviated New Drug Applications
The US Food and Drug Administration (FDA) has published a guidance document outlining the acceptability of draft labeling for abbreviated new drug applications (ANDAs), which are used to submit proposed labeling for generic drugs.
Source: Federal Register — Food and Drug AdministrationOpen original release →